Candida Auris

Candida Auris mind map
Recent News
First Known Outbreak
Location
Washington state
Facility
Kindred Hospital Seattle
Confirmation Date
January 31, 2024
Case Details
Initial Case
Month
July
Place
Pierce County
Latest Cases
Number
Four
Status
Confirmed
Infection Source
Unknown
Public Health Measures
Patient Isolation
Disinfecting Cleaning
Notification Process
Other Facilities
When
Emergence in USA
Year
2016
Increase in Infection Rate
Timeframe
2019 to 2021
Rate
200%
Why
Concerns
Drug Resistance
Rapid Spread During COVID-19
What
Definition
Fungal Infection
Classification
Clinical Cases
Colonization/Screening Cases
Where
Geographic Spread
Initial Discovery
Japan
Spread
Global
US Cases
Several States
Who
At Risk Populations
Long-term Acute Care Patients
Patients With Devices
Examples
Catheters
Breathing Tubes
Health Organizations
CDC
Kindred Hospital Seattle
How
Spread Mechanism
Patient-to-Patient
Via Surfaces
Detection
Screening Programs
State Department of Health
Significance
Awareness
Public Health Surveillance
Infection Control Guidelines
Research
Increasing Understanding
Addressing Drug Resistance
Challenges
Drug Resistance
Common Antifungals
Asymptomatic Colonization
Mortality Rate
Invasive Infections
Percentage
45% within 30 days
Way Forward
Recommendations
Screening High-risk Patients
Strict Infection Control
Ongoing Research
Antifungal Development
Surveillance Enhancements

Candida Auris is a significant public health concern due to its resistance to common antifungal medications and its ability to spread rapidly, especially in healthcare settings. It first emerged in the United States in 2016 and has since seen a significant increase in infection rates. The fungus can spread through patient-to-patient contact and contaminated surfaces. Particularly concerning is the fungus’s ability to colonize patients without causing symptoms, which can lead to invasive infections with a high mortality rate. Public health efforts focus on surveillance, strict infection control measures, and ongoing research to address drug resistance and improve detection methods.